Chemotherapy-free treatment in unfit patients aged 75 years and older with DLBCL: toward a new paradigm?

Lancet Healthy Longev. 2022 Jul;3(7):e453-e454. doi: 10.1016/S2666-7568(22)00150-7.

Authors

Fabrice Jardin¹, Hervé Tilly²

Affiliations

¹ Department of Clinical Hematology and INSERM U1245 Unit Research, Centre Henri Becquerel, Rouen University, Rouen 76 038, France. Electronic address: fabrice.jardin@chb.unicancer.fr.
² Department of Clinical Hematology and INSERM U1245 Unit Research, Centre Henri Becquerel, Rouen University, Rouen 76 038, France.

PMID: 36102755
DOI: 10.1016/S2666-7568(22)00150-7

No abstract available

Publication types

Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / adverse effects
Humans
Lymphoma, Large B-Cell, Diffuse* / drug therapy